Definitive HealthcarevsIntel

DH and INTC stock compared: price, dividend, valuation and results, from SEC filings.

DH

Definitive Healthcare Corp.

$1.34

Value $141M

+2.67%
DH's page

INTC

Intel Corporation

$55.84

Value $297B

-6.10%
INTC's page

Definitive Healthcare (DH) has a market value of $141M and Intel (INTC) $297B. Over the last year, with dividends, DH moved -50.7% and INTC +57.7%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    DH$141M

    INTC$297B

    INTC is 2,112 times DH

  • Revenue, 12 months

    DH$227M

    INTC$59.9B

    INTC is 263 times DH

  • Net income, 12 months

    DH-$157M

    INTC-$12.0B

  • Operating margin

    DH-105.4%

    INTC2.9%

    108.3 points apart

  • ROIC

    DH-44.0%

    INTC0.9%

    44.9 points apart

  • P/E

    DH–

    INTC–

  • Dividend yield

    DH0.0%

    INTC0.0%

    About the same

  • 5-year return

    DH-96.9%

    INTC+20.1%

    117.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

DH-96.9%

INTC+20.1%

010020030020222023202420252026
Returns by period
PeriodDHWith dividendsINTCWith dividends
1 year since November 14, 2025-50.7%Price -50.7%+57.7%Price +57.7%
3 years since November 16, 2023-83.1%-44.7% a yearPrice -83.1%+31.0%+9.4% a yearPrice +29.3%
5 years since November 15, 2021-96.9%-50.2% a yearPrice -96.9%+20.1%+3.7% a yearPrice +11.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

DHDefinitive HealthcareINTCIntel

Valuation

DHINTC
Valuation
Price$1.34$55.84
Market value$141M$297B
Enterprise value (EV)$109M$293B
P/E––
P/E, 5-year median––
P/B0.82.6
EV/EBIT–166.2
Free cash flow yield17.2%1.3%

Results and growth

DHINTC
Results and growth
Revenue, 12 months$227M$59.9B
Net income, 12 months-$157M-$12.0B
Free cash flow, 12 months$24M$3.8B
Earnings per share, 12 months-$1.51-$2.42
Revenue growth, year on year-4.2%-0.5%
Revenue growth a year, past+15.3%over 5 years-7.5%over 5 years
EPS growth a year, past––

Margins and returns on capital

DHINTC
Margins and returns on capital
Gross margin75.4%39.9%
Operating margin-105.4%2.9%
Net margin-69.2%-20.1%
ROIC-44.0%0.9%
ROE-58.9%-11.3%

Balance sheet

DHINTC
Balance sheet
Cash$190M$54.0B
Total debt$164M$50.1B
Net debt / EBITDA–-0.3
Interest cover-22.2×1.5×

Dividends and buybacks

DHINTC
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months––
Dividend growth a year, past––
Buyback yield35.2%–
Shareholder yield35.2%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: DH or INTC

Didn't find what you were looking for?

Ask us
Which is bigger, Definitive Healthcare or Intel?

By market value, Intel ($297B) is about 2,112.0 times Definitive Healthcare ($141M), at today's prices.

How did DH and INTC stock do over the last 5 years?

Since November 15, 2021, DH's price moved -96.9% and INTC's +11.3%. With dividends: DH -96.9% (-50.2% a year), INTC +20.1% (+3.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, DH or INTC?

Neither paid a dividend over the last twelve months: Definitive Healthcare and Intel return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, Definitive Healthcare or Intel?

Over the last twelve months, the net margin was -69.2% for Definitive Healthcare and -20.1% for Intel, and the operating margin -105.4% and 2.9%. Revenue was $227M and $59.9B.

Which is the better investment, Definitive Healthcare or Intel?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.